338 related articles for article (PubMed ID: 11932899)
21. Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia.
Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR
J Cancer Res Clin Oncol; 2000 Jan; 126(1):62-7. PubMed ID: 10641752
[TBL] [Abstract][Full Text] [Related]
22. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.
Logsdon MD; Meyn RE; Besa PC; Pugh WC; Stephens LC; Peters LJ; Milas L; Cox JD; Cabanillas F; Brisbay S; Andersen M; McDonnell TJ
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):19-29. PubMed ID: 10219790
[TBL] [Abstract][Full Text] [Related]
24. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53.
Huang C; Kohno N; Inufusa H; Kodama K; Taki T; Miyake M
Am J Pathol; 1999 Sep; 155(3):955-65. PubMed ID: 10487853
[TBL] [Abstract][Full Text] [Related]
26. Expression of p53, bcl-2, and bax as predictors of response to radiotherapy in esophageal cancer.
Shimoji H; Miyazato H; Nakachi A; Kuniyoshi S; Isa T; Shiraishi M; Muto Y; Toda T
Dis Esophagus; 2000; 13(3):185-90. PubMed ID: 11206630
[TBL] [Abstract][Full Text] [Related]
27. Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.
Sturm I; Petrowsky H; Volz R; Lorenz M; Radetzki S; Hillebrand T; Wolff G; Hauptmann S; Dörken B; Daniel PT
J Clin Oncol; 2001 Apr; 19(8):2272-81. PubMed ID: 11304781
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.
Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C
Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):897-902. PubMed ID: 12162767
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers.
Hanaoka T; Nakayama J; Haniuda M; Sato TA
Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516
[TBL] [Abstract][Full Text] [Related]
32. Bax and Bcl-X(L) expression are not related to prognosis in patients with advanced esophageal squamous cell carcinoma.
Natsugoe S; Matsumoto M; Okumura H; Nakashima S; Sakamoto F; Sakita H; Baba M; Takao S; Aikou T
Cancer Lett; 2001 Dec; 174(1):91-7. PubMed ID: 11675156
[TBL] [Abstract][Full Text] [Related]
33. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
34. P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma.
Skirnisdóttir I; Sorbe B; Seidal T
Int J Gynecol Cancer; 2001; 11(2):147-58. PubMed ID: 11328414
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
36. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
37. Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients.
Cho S; Hahm JH; Hong YS
Br J Dermatol; 2001 Apr; 144(4):841-8. PubMed ID: 11298546
[TBL] [Abstract][Full Text] [Related]
38. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
40. Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.
Gallo O; Chiarelli I; Boddi V; Bocciolini C; Bruschini L; Porfirio B
Int J Cancer; 1999 Dec; 84(6):573-9. PubMed ID: 10567901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
